Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Summit Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SMMT
Nasdaq
8731
https://www.smmttx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Summit Therapeutics Inc
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
- Apr 11th, 2024 8:30 pm
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
- Apr 10th, 2024 11:00 am
Insiders Are Buying These 11 Penny Stocks
- Apr 2nd, 2024 9:41 pm
Why Summit Therapeutics Stock Crushed the Market This Week
- Mar 29th, 2024 9:43 pm
Summit Therapeutics Insiders Up US$5.1m On US$5.05m Investment
- Mar 25th, 2024 2:40 pm
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
- Mar 22nd, 2024 11:00 am
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024
- Mar 14th, 2024 11:00 am
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
- Mar 5th, 2024 12:00 pm
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript
- Feb 21st, 2024 1:53 pm
Q4 2023 Summit Therapeutics Inc Earnings Call
- Feb 21st, 2024 6:56 am
Summit Therapeutics Inc (SMMT) Reports Comprehensive 2023 Financial Results and Clinical ...
- Feb 20th, 2024 1:31 pm
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023
- Feb 20th, 2024 12:00 pm
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024
- Feb 14th, 2024 3:29 pm
Summit Therapeutics to Present at Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 12:00 pm
Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2024 2:00 pm
Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 12:30 pm
Insiders hold 82% of Summit Therapeutics Inc. (NASDAQ:SMMT), and they've been buying recently
- Nov 27th, 2023 11:38 am
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript
- Nov 8th, 2023 5:27 pm
Summit Therapeutics Inc (SMMT) Reports Q3 Financial Results and Operational Progress
- Nov 7th, 2023 2:07 pm
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
- Nov 7th, 2023 12:00 pm
Scroll